Free Trial

Catheter Precision Q2 2024 Earnings Report

Catheter Precision logo
$0.35 -0.01 (-2.53%)
As of 02/21/2025 04:10 PM Eastern

Catheter Precision EPS Results

Actual EPS
-$5.57
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Catheter Precision Revenue Results

Actual Revenue
$0.09 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Catheter Precision Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Catheter Precision Earnings Headlines

Catheter Precision to attend, participate in ISLAA
Elon Social Security shock?
“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One Boston based think tank believes it could have drastic impacts on your money and life in America.
See More Catheter Precision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email.

About Catheter Precision

Catheter Precision (NYSEAMERICAN:VTAK) designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

View Catheter Precision Profile

More Earnings Resources from MarketBeat